Medicine guide
Bextra
·
- Prescription status not stated
- Muscles, joints and bones
- Active substance
- Valdecoxib
- Used in
- Muscles, joints and bones
- Made by
- Pharmacia - Pfizer EEIG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Symptomatic relief in the treatment of osteoarthritis or rheumatoid arthritis.Treatment of primary dysmenorrhoea. The decision to prescribe a selective COX-2 inhibitor should be based on an assessment of the individual patient's overall risk (see sections 4.3, 4.4).
From the official label · 2026-09-30 · European Medicines Agency
Details
| Made by | Pharmacia - Pfizer EEIG |
|---|---|
| Active substance | Valdecoxib |
| Used in | Muscles, joints and bones |
| Classification | M01AH03 · Muscles, joints and bones |
| Authorised on | 2003-03-27 |
| Last updated by the regulator | 2010-02-03 |
| EMA product number | EMEA/H/C/000431 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.